VOR – vor biopharma inc. (US:NASDAQ)
Stock Stats
News
Vor Biopharma (NASDAQ:VOR) had its "neutral" rating reaffirmed by analysts at Wedbush. They now have a $9.00 price target on the stock.
Vor Biopharma (NASDAQ:VOR) had its price target lowered by analysts at HC Wainwright from $55.00 to $32.00. They now have a "buy" rating on the stock.
Vor Biopharma (NASDAQ:VOR) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
Vor Bio Announces Pricing of Public Offering of $100 Million of Common Stock
Vor Bio Announces Proposed Public Offering of $100 Million of Common Stock
Form 424B3 Vor Biopharma Inc.
Form SCHEDULE 13G Vor Biopharma Inc. Filed by: Paradigm Biocapital Advisors LP
Form SCHEDULE 13D/A Vor Biopharma Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Form 8-K Vor Biopharma Inc. For: Nov 10
Form 424B5 Vor Biopharma Inc.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.